In contrast to the present clinical strategy, which focuses mostly on treating symptoms, regenerative medicine aims to restore tissue or organs that have been damaged by disease, trauma, or congenital abnormalities. Tissue engineering, cellular therapy, medicinal gadgets, and artificial organs are among the technologies employed to achieve these goals. Regenerative Medicine is a promising discipline that aims to restore the structure and function of damaged tissues and organs. It's also focused on developing treatments for organs that have been irreparably damaged. The purpose of this strategy is to develop a technique to treat injuries and diseases that were previously untreatable. The discovery of medicines that can regenerate tissues and reduce dependency on transplants is motivated by the loss of organs and tissues due to disease and damage. Regenerative medicine is an interdisciplinary field that uses engineering and life science principles to stimulate regeneration in damaged and wounded tissues and organs. Beyond disease treatment, regenerative medicine seeks out and develops therapies that help the body repair, regenerate, and restore itself to a healthy state.
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India